Outcomes Of Single-Layer Extramucosal Colostomy Closure With Full-Thickness (All-Layers) Colostomy Closure

February 9, 2026 updated by: Muhammad Adeel Ashiq, Children Hospital and Institute of Child Health, Lahore

Comparison of Outcomes Of Single-Layer Extramucosal Colostomy Closure With Full-Thickness (All-Layers) Colostomy Closure In Paediatric Patients

to compare the clinical outcomes of single-layer extramucosal colostomy closure with full-thickness (all-layers) colostomy closure in paediatric patients.

Materials and Methods:

This randomised controlled trial was conducted in the Department of Paediatric Surgery, Bahawal Victoria Hospital, Bahawalpur, from March 2021 to March 2022. A total of 52 paediatric patients undergoing colostomy reversal for anorectal malformations, intestinal obstruction, or blunt abdominal trauma were enrolled. They were randomly allocated into two groups: Group A underwent full-thickness colostomy closure, whereas Group B underwent single-layer extramucosal closure. Patients were followed for 30 days postoperatively. Primary outcomes included anastomotic leak and anastomotic stricture. Secondary outcomes included operative time and duration of hospital stay. Statistical analysis was performed using SPSS 21, with p ≤0.05 considered significant.

Study Overview

Detailed Description

INTRODUCTION Restoration of bowel continuity following colostomy requires meticulous intestinal anastomosis. The optimal technique continues to be debated, with the two commonly used methods being single-layer extramucosal anastomosis and full-thickness (all-layers) anastomosis. Historically, Halsted advocated extramucosal suturing and discouraged mucosal penetration, emphasising tissue preservation and improved healing. Contemporary literature supports single-layer techniques due to reduced tissue trauma, shorter operative time and lower cost, without compromising anastomotic integrity.

Colostomy reversal is frequently required in paediatric surgical practice, especially for anorectal malformations, Hirschsprung disease and intestinal perforations. Anastomotic leak remains the most critical postoperative complication, with rates reported between 1-7%. Leaks significantly increase morbidity, re-operation rates and hospital stay. Anastomotic stricture is another problematic long-term complication contributing to bowel obstruction.

Evidence suggests that single-layer extramucosal anastomosis may reduce luminal narrowing, preserve submucosal vascular plexus and provide comparable leak rates. However, data specific to paediatric colostomy closure remain limited.

This study was conducted to compare the effectiveness of single-layer extramucosal versus full-thickness colostomy closure in paediatric patients, focusing on operative time, anastomotic integrity and postoperative recovery.

________________________________________ MATERIALS & METHODS Study design and setting A randomised controlled trial was conducted in the Department of Paediatric Surgery, Bahawal Victoria Hospital, Bahawalpur, from March 2021 to March 2022.

Sample size and sampling A total of 52 patients (26 per group) were included. Sample size was calculated at 90% power and 95% confidence level. Patients were allocated into two groups through sealed-envelope randomisation.

Inclusion criteria

  • Age ≤12 years
  • Both genders
  • Colostomy for:

    • Anorectal malformations
    • Intestinal obstruction
    • Blunt abdominal trauma Exclusion criteria
  • Neonates and infants
  • Multiple congenital anomalies
  • Complicated prior surgery
  • Patients unfit for general anaesthesia Preoperative assessment

All patients underwent:

  • CBC
  • LFTs
  • Viral screening
  • Serum electrolytes
  • Distal loopogram Patients were kept NPO for 12 hours preoperatively and received rectal enemas. Prophylactic antibiotics were administered.

Operative technique Under general anaesthesia, the colostomy was mobilised. After confirming patency, bowel ends were prepared for anastomosis.

  • Group A: Full-thickness (all-layers) anastomosis using inner full-thickness and outer seromuscular sutures.
  • Group B: Single-layer interrupted extramucosal anastomosis using 3-0 Vicryl. Nasogastric decompression and standard postoperative monitoring were provided. Postoperative care and follow-up
  • NG tube removed once bowel sounds returned
  • Gradual reintroduction of oral feeds
  • Patients discharged on oral antibiotics
  • Follow-up at 7 days and 30 days Outcome measures

Primary outcomes:

  • Anastomotic leak
  • Anastomotic stricture

Secondary outcomes:

  • Duration of operation
  • Duration of hospital stay Statistical analysis SPSS 21.0 was used.
  • Quantitative variables → mean ± SD, independent t-test
  • Categorical variables → frequencies, percentages, Fisher exact test
  • p ≤0.05 considered significant

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 42000
        • CHUCHS, Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Age ≤12 years

    • Both genders
    • Colostomy for:

      • Anorectal malformations
      • Intestinal obstruction
      • Blunt abdominal trauma

Exclusion Criteria:

  • • Neonates and infants

    • Multiple congenital anomalies
    • Complicated prior surgery
    • Patients unfit for general anaesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: extramucosal closure
colostomy closure done with extramucosal suturing
stoma closed with extramucosal sutures
Experimental: full thickness
colostomy closure done with full thickness suturing
stoma closed with full thickness sutures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anastomosis leakage
Time Frame: 7 Days
leakage assessed by pneumoperitineum and abdominal signs
7 Days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Mirza B, et al. Stoma reversal outcomes. J Pediatr Surg Case Rep. 2020.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Actual)

April 1, 2025

Study Completion (Actual)

May 1, 2025

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • adeel 9

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

will decide once sure

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anastomotic Stenosis

Clinical Trials on extramucasal colostomy closure

Subscribe